Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online June 1, 2014.
Article Versions
- You are currently viewing a Latest version of this article (June 1, 2014 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2014 The Journal of Rheumatology
Author Information
- Filip De Keyser,
- Joris De Kock,
- Hermine Leroi,
- Patrick Durez and
- René Westhovens, the Infliximab EAP Study Group
- Belgium From Department BVBA; Department of Rheumatology, of Rheumatology, Ghent University, Pôle deGhent; Recherche MSD en Rhumatologie, Université Catholique Institut de de Louvain Recherche and Expérimentale Cliniques Universitaires et Clinique, Saint-Luc, of Brussels; Development Skeletal and Biology Regeneration and Engineering KU Leuven; Research and Department Center, Department of Rheumatology, Supported University; Department F. De Keyser, by H. of an MD; Leroi, Rheumatology, University unrestricted J. MSD De Kock, Hospitals Belgium educational Pôle MD, de BVBA, Leuven, Department Recherche grant Brussels; Leuven, from of en Rheumatology, Rhumatologie, MSD Belgium.
P. Durez, Belgium.
MD, Ghent Institut de Recherche Expérimentale et Clinique, Université Catholique de Development Louvain PhD, Skeletal and Cliniques and Biology Regeneration and Universitaires Engineering KU Leuven; Saint-Luc; Research and Department R. Center, Westhovens, Department of MD, of Rheumatology, University Hospitals Leuven.
Address 0K12, Department correspondence of Rheumatology, to Prof. De Keyser, De Pintelaan Ghent 185, University B-9000 Hospital Ghent, Belgium. E-mail: filip.dekeyser@ugent.be Accepted for publication March 26, 2014.